AK

Anil Kumar

Active Director Director DIN 02895544
DIN 02895544 First appointment Feb 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2010
Shareholding value •••• Premium profile

About Anil Kumar

Data last updated:

Anil Kumar is a Director at Array Pharmaceuticals Private Limited (since 2010). The company operates in Pharma. Array Pharmaceuticals Private Limited reported revenue of ₹17.5 Lakh (FY 2016).

DIN 02895544
Primary Designation Director
Industry Pharma
First Appointment 08 Feb 2010
Oldest Company Age 19 yrs
Largest company Array Pharmaceuticals Private Limited · ₹17.5 Lakh (FY 2016)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Feb 20102007₹17.5 Lakh (FY 2016)Active

Board colleagues of Anil Kumar

NameDINCompanyDesignation
Sawita Dalal08581320Array Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Array Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anil Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Kumar

Anil Kumar currently holds 1 directorship: Array Pharmaceuticals Private Limited (Director, since 08 Feb 2010, revenue ₹17.5 Lakh (FY 2016)).

Anil Kumar was first appointed on 08 Feb 2010 as Director at Array Pharmaceuticals Private Limited.

The current boards of Anil Kumar's companies include Sawita Dalal (Array Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available